532
Views
12
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma

, , , , , , , , & show all
Pages 276-282 | Received 24 Feb 2015, Accepted 22 May 2015, Published online: 19 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Kalasekhar Vijayasekharan, Anand KC, Maya Prasad, Chetan Dhamne, Nirmalya Roy Moulik, Tanuja Shet, Epari Sridhar, Siddhartha Laskar, Seema Kembhavi, Sneha Shah, Sumeet Gujral, Gaurav Narula & Shripad D. Banavali. (2022) Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India. Pediatric Hematology and Oncology 39:5, pages 427-440.
Read now
Colin Phipps, Yuh Shan Lee, Hao Ying, Chandramouli Nagarajan, Nicholas Grigoropoulos, Yunxin Chen, Tiffany Tang, Alan Z. Goh, Aditi Ghosh, Heng Joo Ng, Sathish Gopalakrishnan, Yvonne Loh, Soon Thye Lim, William Hwang, Daryl Tan & Yeow Tee Goh. (2018) The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma. Leukemia & Lymphoma 59:10, pages 2336-2341.
Read now
Rahul R. Parikh, Michael. L. Grossbard, Louis. B. Harrison & Joachim Yahalom. (2016) Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma. Leukemia & Lymphoma 57:5, pages 1074-1082.
Read now
Edward G. Brooks, Joseph M. Connors, Laurie H. Sehn, Randy D. Gascoyne, Kerry J. Savage, Tamara N. Shenkier, Richard Klasa, Alina S. Gerrie, Brian Skinnider, Graham W. Slack & Diego Villa. (2016) Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma. Leukemia & Lymphoma 57:4, pages 872-879.
Read now

Articles from other publishers (8)

Gabriel Roman Souza, Zohra Nooruddin, Sophia Lee, Lauren Boyle, Kana Tai Lucero, Snegha Ananth, Kathleen Franklin, Michael Mader, Esteban Toro Velez, Amna Naqvi & Supreet Kaur. (2023) The Impact of Time from Diagnosis to Initiation of Chemotherapy on Survival of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, An Ohigashi, Yuka Morita, Taichi Tamura, Shohei Nakamura, Akihiko Kageyama, Yasushi Omuro & Tatsu Shimoyama. (2022) Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study. BMC Cancer 22:1.
Crossref
Chao Ma & Haoyu Li. (2021) Hub Gene and Its Key Effects on Diffuse Large B-Cell Lymphoma by Weighted Gene Coexpression Network Analysis. BioMed Research International 2021, pages 1-13.
Crossref
Masahiro Yoshida, Yosuke Nakaya, Katsujun Shimizu, Naoko Tatsumi, Minako Tsutsumi, Hoyuri Fuseya, Mirei Horiuchi, Takuro Yoshimura, Yoshiki Hayashi, Takafumi Nakao, Takeshi Inoue & Takahisa Yamane. (2021) Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma. Scientific Reports 11:1.
Crossref
Shannon Nixon, Ksenia Bezverbnaya, Manjula Maganti, Patrick Gullane, Michael Reedijk, John Kuruvilla, Anca Prica, Robert Kridel, Vishal Kukreti, Sabrina Bennett, Patrik Rogalla, Jan Delabie, Melania Pintilie & Michael Crump. (2020) Evaluation of Lymphadenopathy and Suspected Lymphoma in a Lymphoma Rapid Diagnosis Clinic. JCO Oncology Practice 16:1, pages e29-e36.
Crossref
Carolina Paz Galvani & Andrea Helena Casale. (2020) Manifestaciones neurológicas de linfoma sistémico en pacientes con VIH/SIDA. Neurología Argentina 12:1, pages 13-19.
Crossref
Shin Lee, Kei Fujita, Eiju Negoro, Tetsuji Morishita, Hideaki Yamauchi, Kana Oiwa, Takanori Ueda & Takahiro Yamauchi. (2019) The impact of diagnostic wait time on the survival of patients with diffuse large B‐cell lymphoma: effect modification by the International Prognostic Index. British Journal of Haematology 187:2, pages 195-205.
Crossref
Tarec C. El‐Galaly, Chan Y. Cheah & Diego Villa. (2019) Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls. British Journal of Haematology 186:3, pages 409-419.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.